Sesen Bio’s stock rocked on heavy volume after shock FDA decision on BLA for cancer treatment
Shares of Sesen Bio Inc.
SESN,
-57.23%
was rocked for a more than 75.4% loss on massive volume in afternoon trading Friday, after the company focused on cancer treatments shocked investors by saying it received a Complete Response Letter (CRL) from the…
